Canada - English - Health Canada

accord healthcare inc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate 50 mg in 5 ml

United States - English - NLM (National Library of Medicine)

attix pharmaceuticals inc - atracurium besylate (unii: 40ax66p76p) (atracurium besylate - unii:40ax66p76p) - atracurium besylate 25 kg in 25 kg

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - cisatracurium besilate -

Ireland - English - HPRA (Health Products Regulatory Authority)

as kalceks - atracurium besilate - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; atracurium

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.

United States - English - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - atracurium besylate (unii: 40ax66p76p) (atracurium - unii:2gq1iry63p) - atracurium besylate injection is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. atracurium besylate is contraindicated in patients known to have a hypersensitivity to it. use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol.